The evolution of antifungal therapy: Traditional agents, current challenges and future perspectives
Fungal infections kill more than 3 million people every year. This high number reflects the significant challenges that treating these diseases worldwide presents. The current arsenal of antifungal drugs is limited and often accompanied by high toxicity to patients, elevated treatment costs, increas...
Saved in:
Main Authors: | Cássia Milena de Souza, Bárbara Tavares Bezerra, Daniel Agreda Mellon, Haroldo Cesar de Oliveira |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Current Research in Microbial Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666517425000033 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel 2-Thiazolylhydrazone with Druggable Properties for Antifungal Application
by: Wallace Cordeiro de Morais, et al.
Published: (2025-01-01) -
Synergistic potential of α-Phellandrene combined with conventional antifungal agents and its mechanism against antibiotic resistant Candida albicans
by: Riya Bhattacharya, et al.
Published: (2024-02-01) -
Chemometric Methods—A Valuable Tool for Investigating the Interactions Between Antifungal Drugs (Including Antifungal Antibiotics) and Food
by: Agnieszka Wiesner-Kiełczewska, et al.
Published: (2025-01-01) -
Novel mitochondrial-targeted alkyl chains act as fungal specific inhibitors of C. neoformans
by: Elizabeth S. M. Edrich, et al.
Published: (2025-02-01) -
Efficacy and Safety Assessment of Antifungal Prophylaxis with Posaconazole Using Therapeutic Drug Monitoring in Pediatric Patients with Oncohematological Disorders—A Single-Centre Study
by: Karolina Liszka, et al.
Published: (2025-01-01)